Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees

Gynecologic Oncology

Volumn 130, Issue 3, 2013, Pages 452-456

  Barlin, Joyce N ^a   Zhou, Qin ^a   St Clair, Caryn M ^a   Iasonos, Alexia ^a   Soslow, Robert A ^a   Alektiar, Kaled M ^a   Hensley, Martee L ^a   Leitao, Mario M ^a,b   Barakat, Richard R ^a,b   Abu Rustum, Nadeem R ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CART analysis; Classification and regression tree analysis; Endometrial cancer; Lymph nodes; Overall survival; Staging

Indexed keywords

ADNEXECTOMY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CHILD; CLASSIFICATION AND REGRESSION TREE; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TUMOR INVASION;

EID: 84882453552     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.06.009     Document Type: Article

References (18)

1. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, J.J. Jobsen, and C.C. Wárlám-Rodenhuis Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
2. R.C. Boronow, C.P. Morrow, W.T. Creasman, P.J. Disaia, S.G. Silverberg, and A. Miller Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study Obstet Gynecol 63 1984 825 832
3. W.T. Creasman, C.P. Morrow, B.N. Bundy, H.D. Homesley, J.E. Graham, and P.B. Heller Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 1987 2035 2041
4. S. Pecorelli Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J Gynaecol Obstet 105 2009 103 104
5. W.T. Creasman The current status of lymphadenectomy in the management of endometrial cancer Womens Health (Lond Engl) 7 2011 33 35
6. L. Breiman, J. Friedman, C.J. Stone, and R.A. Olshen Classification and regression trees 1984 Wadsworth Inc. Belmont (CA)
7. T.M. Therneau An introduction to recursive partitioning using the RPART routine. Technical report 61 1997 Mayo Clinic, Section of Statistics Rochester (MN)
8. E.J. Atkinson An introduction to recursive partitioning using the RPART routine. Technical report 61 2000 Mayo Clinic, Section of Statistics Rochester (MN)
9. ASTEC study group, H. Kitchener, A.M. Swart, Q. Qian, C. Amos, and M.K. Parmar Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study Lancet 373 2009 125 136
10. P. Benedetti Panici, S. Basile, F. Maneschi, A. Alberto Lissoni, M. Signorelli, and G. Scambia Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial J Natl Cancer Inst 100 2008 1707 1716
11. Y. Todo, H. Kato, M. Kaneuchi, H. Watari, M. Takeda, and N. Sakuragi Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis Lancet 375 2010 1165 1172
12. N.R. Abu-Rustum, J.D. Gomez, K.M. Alektiar, R.A. Soslow, M.L. Hensley, and M.M. Leitao Jr. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes Gynecol Oncol 115 2009 236 238
13. M. Ballester, G. Dubernard, F. Lecuru, D. Heitz, P. Mathevet, and H. Marret Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO) Lancet Oncol 12 2011 469 476
14. J.N. Barlin, F. Khoury-Collado, C.H. Kim, M.M. Leitao Jr., D.S. Chi, and Y. Sonoda The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes Gynecol Oncol 125 2012 531 535
15. M.A. Voss, R. Ganesan, L. Ludeman, K. McCarthy, R. Gornall, and G. Schaller Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer - a clinical and pathological evaluation Gynecol Oncol 124 2012 15 20
16. R.A. Nout, V.T. Smit, H. Putter, I.M. Jürgenliemk-Schulz, J.J. Jobsen, and L.C. Lutgens Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
17. H.M. Keys, J.A. Roberts, V.L. Brunetto, R.J. Zaino, N.M. Spirtos, and J.D. Bloss A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group Study Gynecol Oncol 92 2004 744 751
18. M.E. Randall, V.L. Filiaci, H. Muss, N.M. Spirtos, R.S. Mannel, and J. Fowler Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study J Clin Oncol 24 2006 36 44